| 國家衛生研究院 |
2006-05 |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
|
Ch'ang, HJ; Wang, CC; Cheng, AL; Hsu, C; Lu, YS; Chang, MC; Lin, JT; Wang, HP; Shiah, HS; Liu, TW; Chang, JY; Whang-Peng, J; Chen, LT |
| 國家衛生研究院 |
2006-05 |
Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan: implication from age-period-cohort analysis
|
Hsu, C;Shen, YC;Cheng, CC;Hong, RL;Chang, CJ;Cheng, AL |
| 國家衛生研究院 |
2006-03 |
Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer
|
Shiah, HS; Cheng, AL; Hsu, C; Hsu, CH; Liu, TW; Chang, JY; Jan, CM; Chao, Y; Yu, WL; Chuang, TR; Whang-Peng, J; Chen, LT |
| 國家衛生研究院 |
2006 |
The impact of the tobacco market opening on smoking status in Taiwan: Findings from a secular smoking rates analysis
|
Hsu, C;Lord, A;Tseng, T;Chen, T |
| 國家衛生研究院 |
2006 |
The interplay of hNinein and Astrin- hNinein is required for targeting Spindle-associated protein Astrin to the centrosome
|
Cheng, T;Hsiao, Y;Lin, C;Hsu, C;Chang, M;Lee, C;Yu, RC;Huang, CF;Howng, S;Hong, Y |
| 臺北醫學大學 |
2006 |
17b-Estradiol Inhibits Subarachnoid Hemorrhage-Induced iNOS Gene Expression by Interfering with the Nuclear Factor Kappa B Transactivation.
|
李文森; Shih HC; Lin CL; Lee TY; Lee WS; Hsu C; |
| 臺北醫學大學 |
2006 |
Predictors of Recurrent Stroke in African Americans
|
許重義; Ruland S; Richardson D; Hung E; Brorson JR; Cruz-Flores S; Felton WL 3rd; Ford-Lynch G; Helgason C; Hsu C; |
| 高雄醫學大學 |
2006 |
雌二醇經由干擾NFkB抑制因蜘蛛膜下腔出血引起的iNOS基因表現
|
施慧娟;林志隆;李姿瑩;李文森;許勤 ; Shih HC;Lin CL;Lee TY;Lee WS;Hsu C |
| 國立臺灣大學 |
2006 |
Rating Certificate Authorities: a market approach to the Lemons problem
|
Backhouse, J.; Baptista, J.; Hsu, C. |
| 國立臺灣大學 |
2006 |
Circuits of Power in Creating de jure Standards: Shaping the International Information Systems Security Standard
|
Backhouse, J; Hsu, C.; Silva, L. |
| 臺大學術典藏 |
2006 |
Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer
|
Yang T.-Y.; Lin C.-P.; Su W.-P.; Gow C.-H.; Hsu C.; Chang G.-C.; Yang P.-C.; CHONG-JEN YU; Chen K.-C.; Yang C.-H.; Shih J.-Y. |
| 淡江大學 |
2005-09 |
Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients
|
Su, W.P.; Wen, C.C.; Hsiung, C.A.; Su, I.J.; Cheng, A.L.; Chang, M.C.; Tsao, C.J.; Kao, W.Y.; Uen, W.C.; Hsu, C.; Hsu, C.H.; Lu, Y.S.; Tien, H.F; Chao, T.Y.; Chen L.T.; Jacqueline Whang-Peng; Chen, P.J. |
| 國家衛生研究院 |
2005-08 |
Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: Implications from age-period-cohort analysis
|
Shen, YC;Chang, CJ;Hsu, C;Cheng, CC;Chiu, CF;Cheng, AL |
| 國立臺灣大學 |
2005-08 |
Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer.
|
Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Hsu, C; Kuo, SH; Li, SJ; Cheng, AL. |
| 國立臺灣大學 |
2005-08 |
Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer.
|
Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Hsu, C; Kuo, SH; Li, SJ; Cheng, AL. |
| 國立東華大學 |
2005-07 |
Exploiting Hardware-accelerated Occlusion Queries for Visibility Culling
|
Yang,M.T.; Hsu,C.; Chiang,C.; Tai,W. |
| 國家衛生研究院 |
2005-05 |
Effect of thalidomide in hepatocellular carcinoma: Assessment with power Doppler US and analysis of circulating angiogenic factors
|
Hsu, C; Chen, CN; Chen, LT; Wu, CY; Hsieh, FJ; Cheng, AL |
| 國立臺灣大學 |
2005-05 |
Strategic planning of developing automatic optical inspection (AOI) technologies in Taiwan
|
Fan, K. C.; Hsu, C. |
| 國家衛生研究院 |
2005 |
Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer
|
Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Hsu, C; Kuo, SH; Li, SJ; Cheng, AL |
| 臺北醫學大學 |
2005 |
Project for Stroke Prevention Center. Prevalence and Arsenic Exposure in Taiwan.
|
邱弘毅; Chiou HY;Chiu WT;Chen YH;Hsieh YC;Hsu C; |
| 高雄醫學大學 |
2005 |
Alteration of protein kinase C isoforms expressions in various regions of rat ventricles during sepsis
|
梁馨仁;許勤;許勝光;呂勝義;楊瑞成;楊秀蘭 ; Liang HJ;Hsu C;Hsu HK;Lue SI;Yang RC;Yang SL |
| 高雄醫學大學 |
2005 |
Role of cAMP-response element-binding protein phosphorylation in hepatic apoptosis under protein kinase C alpha suppression during sepsis.
|
謝雅晶;饒曉菁;許勝光;黃麗如;許勤 ; Hsieh YC;Chen YH;Jao HC;Hsu HK;Huang LJ;Hsu C |
| 高雄醫學大學 |
2005 |
Role of cAMP-response element-binding protein phosphorylation in hepatic apoptosis under protein kinase C alpha suppression during sepsis.
|
陳彥旭; Hsieh, YC;Chen, YH;Jao, HC;Hsu, HK;Huang, LJ;Hsu, C |
| 國立臺灣大學 |
2005 |
Fractionation and identification of pparα activators in the oxidized frying oil
|
Hsu, C; Chao, PM; Kuo, YH; Huang, C-j* |
| 國立臺灣大學 |
2005 |
A Question of Trust-An Economics Analysis of Quality Standards in Certification Services Market
|
Backhouse, J; Hsu, C; Tseng, J; Baptista, J |
| 臺大學術典藏 |
2005 |
Effect of thalidomide in hepatocellular carcinoma: Assessment with power Doppler US and analysis of circulating angiogenic factors
|
Cheng A.-L.; Hsieh F.-J.; Wu C.-Y.; Chen L.-T.; CHIUNG-NIEN CHEN; Hsu C.; Hsu C.;Chiung-Nien Chen;Chen L.-T.;Wu C.-Y.;Hsieh F.-J.;Cheng A.-L. |
| 國立臺灣大學 |
2004-12 |
Use of power Doppler sonography and circulating angiogenic factors to assess the anti-angiogenic effect of thalidomide in hepatocellular carcinoma.
|
Hsu, C; Chen, CN; Chen, LT; Wu, CY; Hsieh, FJ; Cheng, AL |
| 國家衛生研究院 |
2004-10-18 |
Lack of efficacy of troglitazone at clinically achievable concentrations, with or without 9-cis retinoic acid or cytotoxic agents, for hepatocellular carcinoma cell lines
|
Shen, YC; Hsu, C; Chen, JY; Cheng, AL |
| 國立臺灣大學 |
2004-10-05 |
Lack of efficacy of troglitazone at clinically achievable concentrations, with or without 9-cis retinoic acid or cytotoxic agents, for hepatocellular carcinoma cell lines
|
Shen, Y.C.; Hsu, C.; Chen, J.Y.; Cheng, A.L. |
| 國家衛生研究院 |
2004-10 |
Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of hepatocellular carcinoma
|
Cha'ang, H;Lien, P;Tsen, S;Hsu, C;Shih, T |
| 國家衛生研究院 |
2004-07 |
Recent advances in non-surgical treatment for advanced hepatocellular carcinoma
|
Hsu, C;Cheng, JCH;Cheng, AL |
| 國家衛生研究院 |
2004-07 |
Comparison of the antitumor activity of thalidomide between hepatitis B (HBV)and hepatitis C (HCV)-related hepatocellular carcinoma (HCC)
|
Hsu, C;Chen, LT;Lai, MY;Yeh, KH;Lee, PH;Cheng, AL |
| 國家衛生研究院 |
2004-05-04 |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Hsu, C; Shen, YC; Yang, CH; Yeh, KH; Lu, YS; Hsu, CH; Liu, HT; Li, CC; Chen, JS; Wu, CY; Cheng, AL |
| 國立臺灣大學 |
2004-05 |
Phase II study of combination doxorubicin, interferon-alpha, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma.
|
Lu, YS; Hsu, C; Li, CC; Kuo, SH; Kun-Huei, Yeh; Yang, CH; Hsu, CH; Wu, CY; Cheng, AL. |
| 國立臺灣大學 |
2004-05 |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract.
|
Hsu C; Shen YC; Yang CH; Kun-Huei Yeh; Lu YS; Hsu CH; Liu HT; Li CC; Chen JS; Wu CY; Cheng AL |
| 臺大學術典藏 |
2004-05 |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract.
|
Hsu C;Shen YC;Yang CH;Kun-Huei Yeh;Lu YS;Hsu CH;Liu HT;Li CC;Chen JS;Wu CY;Cheng AL; Hsu C; Shen YC; Yang CH; Kun-Huei Yeh; Lu YS; Hsu CH; Liu HT; Li CC; Chen JS; Wu CY; Cheng AL |
| 臺北醫學大學 |
2004 |
Functional domain and motif analysis of androgen receptor coregulator ARA70 and its differential expression in prostate cancer
|
葉劭德; Hu YC; Yeh S; Yeh SD; Sampson ER; Huang J; Li P; Hsu C; Ting HJ; Lin HK; Wang L; Kim E; Ni J; Chang C |
| 臺北醫學大學 |
2004 |
Introduction of prototype for Stroke Prevention Center.
|
邱弘毅; Chiou HY;Chiu WT;Chen YH;Hsieh YC;Hsu C; |
| 臺大學術典藏 |
2004 |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Shen Y.-C.; Yang C.-H.; Yeh K.-H.; Lu Y.-S.; CHIH-HUNG HSU; Liu H.-T.; Hsu C.; Hsu C.;Shen Y.-C.;Yang C.-H.;Yeh K.-H.;Lu Y.-S.;Chih-Hung Hsu;Liu H.-T.;Li C.-C.;Chen J.-S.;Wu C.-Y.;Cheng A.-L.; Cheng A.-L.; Wu C.-Y.; Li C.-C.; Chen J.-S. |
| 國家衛生研究院 |
2003-12 |
Factors contributing to health behaviors among the elderly in Taiwan
|
Hsu, C;Hsu, H;Shu, C;Shih, Y;Tai, T |
| 國立臺灣大學 |
2003-12 |
Low-dose thalidomide treatment for advanced hepatocellular carcinoma.
|
Hsu, C; Chen, CN; Chen, LT; Wu, CY; Yang, PM; Lai, MY; Lee, PH; Cheng, AL |
| 國家衛生研究院 |
2003-11 |
Use of power Doppler sonography and circulating angiogenic factors to assess the potential antiangiogenic effect of thalidomide in hepatocellular carcinoma
|
Hsu, C;Chen, HN;Chen, LT;Wu, CY;Hsieh, FJ;Cheng, AL |
| 國家衛生研究院 |
2003-10 |
An investigation of gradient-based reconstruction algorithms for statistical PET transmission imaging
|
Chang, M;Hsu, C |
| 國立臺灣大學 |
2003-01 |
Rejoinder for “Hsu C, et al. survival-weighted health profile for long-term survivors of acute myelogenous leukemia”.
|
Hsu, C.; Wang, J. D.; Yao, G.; Tang, G. L. |
| 國家衛生研究院 |
2003 |
Low-dose thalidomide treatment for advanced hepatocellular carcinoma
|
Hsu, C; Chen, CN; Chen, LT; Wu, CY; Yang, PM; Lai, MY; Lee, PH; Cheng, AL |
| 高雄醫學大學 |
2003 |
熱修克前處理可預防敗血症時心臟粒線體功能缺失
|
陳香文;許勤;呂宗禧;王淑容;楊瑞成 ; Chen HW;Hsu C;Lu TS;Wang SJ;Yang RC |
| 高雄醫學大學 |
2003 |
Low-dose thalidomide treatment for advanced hepatocellular carcinoma.
|
陳立宗;鄭安理 ; Hsu C;Chen CN;Chen LT;Wu CY;Yang PM;Lai MY;Lee PH;Cheng AL. |
| 高雄醫學大學 |
2003 |
抑制PKC alpha可經由負向調控Bcl-xL而引起肝臟上皮細胞的凋亡
|
謝雅晶;饒曉菁;楊瑞成;許勝光;許勤 ; Hsieh YC;Jao HC;Yang RC;Hsu HK;Hsu C |
| 國立臺灣大學 |
2003 |
Towards PKI Interoperability: Lessons from a BS7799 Accreditation Scheme
|
Backhouse, J.; Hsu, C; McDonell, A. |
| 臺大學術典藏 |
2003 |
Strong green luminescence in quaternary InAlGaN thin films
|
Feng, S.-W.; Cheng, Y.-C.; Chung, Y.-Y.; Yang, C.C.; Ma, K.-J.; Yan, C.-C.; Hsu, C.; Lin, J.Y.; Jiang, H.X.; CHIH-CHUNG YANG |
